First Time Loading...

Samsung Biologics Co Ltd
KRX:207940

Watchlist Manager
Samsung Biologics Co Ltd Logo
Samsung Biologics Co Ltd
KRX:207940
Watchlist
Price: 750 000 KRW -1.32% Market Closed
Updated: Jun 9, 2024

Samsung Biologics Co Ltd
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Samsung Biologics Co Ltd
Other Liabilities Peer Comparison

Comparables:
P
087010
S
237690
F
220100
L
141080
C
268600

Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Samsung Biologics Co Ltd
KRX:207940
Other Liabilities
₩417.5B
CAGR 3-Years
24%
CAGR 5-Years
33%
CAGR 10-Years
N/A
P
Peptron Inc
KOSDAQ:087010
Other Liabilities
₩3.6B
CAGR 3-Years
10%
CAGR 5-Years
14%
CAGR 10-Years
N/A
S
ST Pharm Co Ltd
KOSDAQ:237690
Other Liabilities
₩43B
CAGR 3-Years
105%
CAGR 5-Years
58%
CAGR 10-Years
N/A
F
FutureChem Co Ltd
KOSDAQ:220100
Other Liabilities
₩2.7B
CAGR 3-Years
5%
CAGR 5-Years
4%
CAGR 10-Years
N/A
L
LegoChem Biosciences Inc
KOSDAQ:141080
Other Liabilities
₩3.7B
CAGR 3-Years
-10%
CAGR 5-Years
-6%
CAGR 10-Years
5%
C
Cellivery Therapeutics Inc
KOSDAQ:268600
Other Liabilities
₩587.6m
CAGR 3-Years
-27%
CAGR 5-Years
1%
CAGR 10-Years
N/A

See Also

What is Samsung Biologics Co Ltd's Other Liabilities?
Other Liabilities
417.5B KRW

Based on the financial report for Mar 31, 2024, Samsung Biologics Co Ltd's Other Liabilities amounts to 417.5B KRW.

What is Samsung Biologics Co Ltd's Other Liabilities growth rate?
Other Liabilities CAGR 5Y
33%

Over the last year, the Other Liabilities growth was -58%. The average annual Other Liabilities growth rates for Samsung Biologics Co Ltd have been 24% over the past three years , 33% over the past five years .